Cited by 414Cancer-related Molecular PathwaysHeat shock proteins researchUbiquitin and proteasome pathways

The DOI matches its Crossref record; 57 of the 63 references it cites were found in a registry or an index.

p300/MDM2 Complexes Participate in MDM2-Mediated p53 Degradation

Open access

Grossman, Steven R, Perez, Marco, Kung, Andrew L, Joseph, Michael, Mansur, Claire, Xiao, Zhi-Xiong, Kumar, Sushant, Howley, Peter M, Livingston, David M·1998·Molecular Cell

DOI 10.1016/s1097-2765(00)80140-9

Open this paper in CoChat — free account Open PDF

Abstract

Control of p53 turnover is critical to p53 function. E1A binding to p300/CBP translates into enhanced p53 stability, implying that these coactivator proteins normally operate in p53 turnover control. In this regard, the p300 C/H1 region serves as a specific in vivo binding site for both p53 and MDM2, a naturally occurring p53 destabilizer. Moreover, most of the endogenous MDM2 is bound to p300, and genetic analysis implies that specific interactions of p53 and MDM2 with p300 C/H1 are important steps in the MDM2-directed turnover of p53. A specific role for p300 in endogenous p53 degradation is underscored by the p53-stabilizing effect of overproducing the p300 C/H1 domain. Taken together, the data indicate that specific interactions between p300/CBP C/H1, p53, and MDM2 are intimately involved in the MDM2-mediated control of p53 abundance.

Integrity signals

Registry

Crossref · 10.1016/s1097-2765(00)80140-9

Cites

57 of 57 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

p53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693
High-Efficiency Transformation of Mammalian Cells by Plasmid DNA
Chen, C., & Okayama, H. (1987) · Molecular and Cellular Biology · doi:10.1128/mcb.7.8.2745 · Cited by 5,327
Mdm2 promotes the rapid degradation of p53
Haupt, Y., Maya, R., Kazaz, A., & Oren, M. (1997) · Nature · doi:10.1038/387296a0 · Cited by 4,506
The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53
Scheffner, M., Werness, B. A., Huibregtse, J. M., Levine, A. J., & Howley, P. M. (1990) · Cell · doi:10.1016/0092-8674(90)90409-8 · Cited by 3,995
Self-citation
Regulation of p53 stability by Mdm2
Kubbutat, M. H. G., Jones, S. N., & Vousden, K. H. (1997) · Nature · doi:10.1038/387299a0 · Cited by 3,312
The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation
Momand, J., Zambetti, G. P., Olson, D. C., George, D., & Levine, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90644-r · Cited by 3,113
The Transcriptional Coactivators p300 and CBP Are Histone Acetyltransferases
Ogryzko, V. V., Schiltz, R. L., Russanova, V., Howard, B. H., & Nakatani, Y. (1996) · Cell · doi:10.1016/s0092-8674(00)82001-2 · Cited by 2,952
Activation of p53 Sequence-Specific DNA Binding by Acetylation of the p53 C-Terminal Domain
Gu, W., & Roeder, R. G. (1997) · Cell · doi:10.1016/s0092-8674(00)80521-8 · Cited by 2,559
The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53
Scheffner, M., Huibregtse, J. M., Vierstra, R. D., & Howley, P. M. (1993) · Cell · doi:10.1016/0092-8674(93)90384-3 · Cited by 2,416
Self-citation
p53: puzzle and paradigm.Preprint
Ko, L. J., & Prives, C. L. (1996) · Genes & Development · doi:10.1101/gad.10.9.1054 · Cited by 2,346

Show all 63 references

Sorted by citations

Items 101–200 of 412

Arsenic-interferon-alpha-triggered apoptosis in HTLV-I transformed cells is associated with tax down-regulation and reversal of NF-kappa B activation.
El-Sabban, M. E., Nasr, R., Dbaibo, G. S., Hermine, O., Abboushi, N., Quignon, F., Ameisen, J., Bex, F., de Thé, H., & Bazarbachi, A. A. (2000) · PubMed · doi:10.1182/blood.v96.8.2849 · Cited by 139
Atlas of Genetics and Cytogenetics in Oncology and Haematology
(2011) · Atlas of Genetics and Cytogenetics in Oncology and Haematology · doi:10.4267/2042/15655 · Cited by 138
Regulation of the cell cycle and apoptosis by the oncogenes of adenovirus
White, E. (2001) · Oncogene · doi:10.1038/sj.onc.1204861 · Cited by 141
A novel smad nuclear interacting protein, SNIP1, suppresses p300-dependent TGF-beta signal transduction.
Kim, R. H., Wang, D., Tsang, M., Martin, J. M., Huff, C., de Caestecker, M. P., Parks, W. T., Meng, X., Lechleider, R. J., Wang, T., et al. (2000) · PubMed Central · Cited by 132
A novel Smad nuclear interacting protein, SNIP1, suppresses p300-dependent TGF-β signal transductionPreprint
Kim, R. H., Wang, D., Tsang, M., Martin, J. M., Huff, C., de Caestecker, M. P., Parks, W. T., Meng, X., Lechleider, R. J., Wang, T., et al. (2000) · Genes & Development · doi:10.1101/gad.14.13.1605 · Cited by 130
Inactivation of the p53 pathway in prostate cancer: impact on tumor progression.
Osman, I., Drobnjak, M., Fazzari, M. J., Ferrara, J., Scher, H. I., & Cordon‐Cardo, C. (1999) · PubMed · Cited by 131
Skp2 suppresses p53-dependent apoptosis by inhibiting p300.
Kitagawa, M., Lee, S. H., & McCormick, F. (2008) · Molecules and Cells · doi:10.1016/j.molcel.2007.11.036 · Cited by 122
The Corepressor mSin3a Interacts with the Proline-Rich Domain of p53 and Protects p53 from Proteasome-Mediated Degradation
Zilfou, J. T., Hoffman, W. H., Sank, M. J., George, D. L., & Murphy, M. E. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.12.3974-3985.2001 · Cited by 129
Structural Basis for p300 Taz2-p53 TAD1 Binding and Modulation by Phosphorylation
Feng, H., Jenkins, L. M. M., Durell, S. R., Hayashi, R., Mazur, S. J., Cherry, S., Tropea, J. E., Miller, M., Wlodawer, A., Appella, E., et al. (2009) · Structure · doi:10.1016/j.str.2008.12.009 · Cited by 134
Dysregulation of cellular signaling by HER2 in breast cancer
Zhou, B. P. (2003) · Seminars in Oncology · doi:10.1053/j.seminoncol.2003.08.006 · Cited by 127
Mdm2 Induces Mono-Ubiquitination of FOXO4
Brenkman, A. B., de Keizer, P. L. J., van den Broek, N. J. F., Jochemsen, A. G., & Burgering, B. M. T. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002819 · Cited by 132
A Novel Transcriptional Repression Domain Mediates p21WAF1/CIP1 Induction of p300 Transactivation
Snowden, A. W., Anderson, L. A., Webster, G., & Perkins, N. D. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.8.2676-2686.2000 · Cited by 126
Regulation and function of the p53-related proteins: same family, different rules
Lohrum, M. A. E., & Vousden, K. H. (2000) · Trends in Cell Biology · doi:10.1016/s0962-8924(00)01736-0 · Cited by 122
Defining the molecular basis of Arf and Hdm2 interactions
Bothner, B. B., Lewis, W. S., DiGiammarino, E. L., Weber, J. D., Bothner, S. J., & Kriwacki, R. W. (2001) · Journal of Molecular Biology · doi:10.1006/jmbi.2001.5110 · Cited by 122
Regulation of E2F: a family of transcription factors involved in proliferation control
Black, A. R., & Azizkhan‐Clifford, J. (1999) · Gene · doi:10.1016/s0378-1119(99)00305-4 · Cited by 121
p53 N-terminal phosphorylation: a defining layer of complex regulation
Jenkins, L. M. M., Durell, S. R., Mazur, S. J., & Appella, E. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs145 · Cited by 122
Increased apoptosis induction by 121F mutant p53
Saller, E., Tom, E., Brunori, M., Otter, M., Estreicher, A., Mack, D. H., & Iggo, R. D. (1999) · The EMBO Journal · doi:10.1093/emboj/18.16.4424 · Cited by 124
Adenovirus and cell cycle control
Ben-Israel, H. (2002) · Frontiers in bioscience · doi:10.2741/ben · Cited by 117
The versatile functions of the transcriptional coactivators p300 and CBP and their roles in disease.
Janknecht, R. (2002) · PubMed · doi:10.14670/hh-17.657 · Cited by 117
Mitochondrial Dysfunction in Pten Haplo-Insufficient Mice with Social Deficits and Repetitive Behavior: Interplay between Pten and p53
Napoli, E., Ross‐Inta, C., Wong, S., Hung, C., Fujisawa, Y., Sakaguchi, D., Angelastro, J. M., Omanska-Klusek, A., Schoenfeld, R. A., & Giulivi, C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042504 · Cited by 116
Phosphorylation-Dependent Degradation of p300 by Doxorubicin-Activated p38 Mitogen-Activated Protein Kinase in Cardiac Cells
Poizat, C. I., Puri, P., Bai, Y., & Kedes, L. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.7.2673-2687.2005 · Cited by 116
DNA-dependent Acetylation of p53 by the Transcription Coactivator p300
Dornan, D., Shimizu, H., Perkins, N. D., & Hupp, T. R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211460200 · Cited by 120
HIV-1 viral infectivity factor interacts with TP53 to induce G2 cell cycle arrest and positively regulate viral replication
Izumi, T., Io, K., Matsui, M., Shirakawa, K., Shinohara, M., Nagai, Y., Kawahara, M., Kobayashi, M., Kondoh, H., Misawa, N., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1008076107 · Cited by 109
Epstein-Barr Virus Nuclear Antigen 3C Augments Mdm2-Mediated p53 Ubiquitination and Degradation by Deubiquitinating Mdm2
Saha, A., Murakami, M., Kumar, P., Bajaj, B. G., Sims, K., & Robertson, E. S. (2009) · Journal of Virology · doi:10.1128/jvi.02408-08 · Cited by 120
Mapping the Interactions of the p53 Transactivation Domain with the KIX Domain of CBP
Lee, C. W., Arai, M., Martinez‐Yamout, M. A., Dyson, H. J., & Wright, P. E. (2009) · Biochemistry · doi:10.1021/bi802055v · Cited by 118
Cells Degrade a Novel Inhibitor of Differentiation with E1A-Like Properties upon Exiting the Cell Cycle
Miyake, S., Sellers, W. R., Safran, M., Li, X., Zhao, W., Grossman, S. R., Gan, J., DeCaprio, J. A., Adams, P. D., & Kaelin, W. G. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.23.8889-8902.2000 · Cited by 112
Self-citation
Recognition of the disordered p53 transactivation domain by the transcriptional adapter zinc finger domains of CREB-binding protein
Krois, A. S., Ferreon, J. C., Martinez‐Yamout, M. A., Dyson, H. J., & Wright, P. E. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1602487113 · Cited by 113
MDM2 Associates with Polycomb Repressor Complex 2 and Enhances Stemness-Promoting Chromatin Modifications Independent of p53
Wienken, M., Dickmanns, A., Nemajerová, A., Kramer, D., Najafova, Z., Weiss, M., Karpiuk, O., Kassem, M. S., Zhang, Y., Lozano, G., et al. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.12.008 · Cited by 116
Identification of Three Functions of the Adenovirus E4orf6 Protein That Mediate p53 Degradation by the E4orf6-E1B55K Complex
Querido, E., Morrison, M. R., Dang, H. C. P., Thirlwell, S. W.-L., Boivin, D., & Branton, P. E. (2001) · Journal of Virology · doi:10.1128/jvi.75.2.699-709.2001 · Cited by 110
ARF Function Does Not Require p53 Stabilization or Mdm2 Relocalization
Korgaonkar, C. K., Zhao, L., Modestou, M., & Quelle, D. E. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.1.196-206.2002 · Cited by 111
Binding of p53 to the KIX Domain of CREB Binding Protein
Orden, K. V., Giebler, H. A., Lemasson, I., Gonzales, M. S., & Nyborg, J. K. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.37.26321 · Cited by 111
A novel 3’tRNA-derived fragment tRF-Val promotes proliferation and inhibits apoptosis by targeting EEF1A1 in gastric cancer
Cui, H.-P., Li, H.-W., Wu, H., Du, F., Xie, X., Zeng, S.-J., Zhang, Z.-H., Dong, K., Shang, L., Jing, C., et al. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-04930-6 · Cited by 109
Inhibition of p53 degradation by Mdm2 acetylation
Wang, X., Taplick, J., Geva, N., & Oren, M. (2004) · FEBS Letters · doi:10.1016/s0014-5793(04)00168-1 · Cited by 112
Acetylation regulates the differentiation‐specific functions of the retinoblastoma protein
Nguyen, D. X., Baglia, L. A., Huang, S.-M. A., Baker, C. M., & McCance, D. J. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600176 · Cited by 108
Critical Role of Cysteine Residue 81 of Macrophage Migration Inhibitory Factor (MIF) in MIF-induced Inhibition of p53 Activity
Jung, H., Seong, H., & Ha, H. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800050200 · Cited by 106
HOXA5-Twist Interaction Alters p53 Homeostasis in Breast Cancer Cells
Stasinopoulos, I. A., Mironchik, Y., Raman, A., Wildes, F. B., Winnard, P., & Raman, V. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m411018200 · Cited by 107
Proteasome-Mediated Degradation of the Coactivator p300 Impairs Cardiac Transcription
Poizat, C. I., Sartorelli, V., Chung, G., Kloner, R. A., & Kedes, L. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.23.8643-8654.2000 · Cited by 108
p300 Interacts with the Nuclear Proto-Oncoprotein SYT as Part of the Active Control of Cell Adhesion
Eid, J. E., Kung, A. L., Scully, R., & Livingston, D. M. (2000) · Cell · doi:10.1016/s0092-8674(00)00072-6 · Cited by 105
Self-citation
c-Abl Neutralizes the Inhibitory Effect of Mdm2 on p53
Sionov, R. V., Moallem, E., Berger, M., Kazaz, A., Gerlitz, O., Ben‐Neriah, Y., Oren, M., & Haupt, Y. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.13.8371 · Cited by 104
Small-molecule MDM2 inhibitors in clinical trials for cancer therapy
Wang, S., & Chen, F. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.114334 · Cited by 104
Endoplasmic Reticulum Stress Accelerates p53 Degradation by the Cooperative Actions of Hdm2 and Glycogen Synthase Kinase 3β
Pluquet, O., Qu, L., Baltzis, D., & Koromilas, A. E. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.21.9392-9405.2005 · Cited by 106
MDM2’s social network
Fåhræus, R., & Olivares‐Illana, V. (2013) · Oncogene · doi:10.1038/onc.2013.410 · Cited by 103
Melatonin down‐regulates MDM 2 gene expression and enhances p53 acetylation in MCF ‐7 cells
Proietti, S., Cucina, A., Dobrowolny, G., D’Anselmi, F., Dinicola, S., Masiello, M. G., Pasqualato, A., Palombo, A., Morini, V., Reiter, R. J., et al. (2014) · Journal of Pineal Research · doi:10.1111/jpi.12150 · Cited by 99
The N-Terminal Domain of p73 Interacts with the CH1 Domain of p300/CREB Binding Protein and Mediates Transcriptional Activation and Apoptosis
Zeng, X., Li, X., Miller, A., Yuan, Z.-M., Yuan, W., Kwok, R. P. S., Goodman, R. H., & Lu, H. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.4.1299-1310.2000 · Cited by 97
Inhibition of p53 function diminishes androgen receptor-mediated signaling in prostate cancer cell lines
Cronauer, M. V., Schulz, W. A., Burchardt, T., Ackermann, R., & Burchardt, M. (2004) · Oncogene · doi:10.1038/sj.onc.1207346 · Cited by 95
Mdm2 facilitates the association of p53 with the proteasome
Kulikov, R., Letienne, J., Kaur, M., Grossman, S. R., Arts, J., & Blattner, C. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0911716107 · Cited by 94
Self-citation
Murine Double Minute (MDM2) Blocks p53-coactivator Interaction, a New Mechanism for Inhibition of p53-dependent Gene Expression
Wadgaonkar, R., & Collins, T. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.20.13760 · Cited by 97
A Novel Cellular Protein (MTBP) Binds to MDM2 and Induces a G1 Arrest That Is Suppressed by MDM2
Boyd, M. T., Vlatković, N., & Haines, D. S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004252200 · Cited by 93
Inhibition of p53‐dependent transcription by BOX‐I phospho‐peptide mimetics that bind to p300
Dornan, D., & Hupp, T. R. (2001) · EMBO Reports · doi:10.1093/embo-reports/kve025 · Cited by 93
Chlamydia infection depends on a functional MDM2-p53 axis
González, E., Rother, M., Kerr, M. C., Al‐Zeer, M. A., Lubad, M. A., Kessler, M., Brinkmann, V., Loewer, A., & Meyer, T. F. (2014) · Nature Communications · doi:10.1038/ncomms6201 · Cited by 93
Distinct Regulation of p53 and p73 Activity by Adenovirus E1A, E1B, and E4orf6 Proteins
Steegenga, W. T., Shvarts, A., Riteco, N., Bos, J. L., & Jochemsen, A. G. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.5.3885 · Cited by 93
Oncogenic Ras Induces p19ARF and Growth Arrest in Mouse Embryo Fibroblasts Lacking p21Cip1 and p27Kip1 without Activating Cyclin D-dependent Kinases
Groth, A., Weber, J. D., Willumsen, B. M., Sherr, C. J., & Roussel, M. F. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003417200 · Cited by 92
Cyclin D1 Represses p300 Transactivation through a Cyclin-dependent Kinase-independent Mechanism
Fu, M., Wang, C., Rao, M., Wu, X., Bouras, T., Zhang, X., Li, Z., Jiao, X., Yang, J., Li, A., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m503188200 · Cited by 91
Self-citation
The human papillomavirus E7 oncoprotein as a regulator of transcription
Songock, W. K., Kim, S., & Bodily, J. M. (2016) · Virus Research · doi:10.1016/j.virusres.2016.10.017 · Cited by 97
The contribution of the acidic domain of MDM2 to p53 and MDM2 stability
Argentini, M., Barboule, N., & Wasylyk, B. (2001) · Oncogene · doi:10.1038/sj.onc.1204241 · Cited by 90
Regulation and activation of p53 and its family members
Lohrum, M. A. E., & Vousden, K. H. (1999) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400625 · Cited by 91
Cutaneous Papillomavirus E6 Proteins Must Interact with p300 and Block p53-Mediated Apoptosis for Cellular Immortalization and Tumorigenesis
Muench, P., Probst, S., Schuetz, J., Leiprecht, N., Busch, M., Wesselborg, S., Stubenrauch, F., & Iftner, T. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1307 · Cited by 92
Novel targets of Akt, p21, and MDM2
Zhou, B. P., & Hung, M. (2002) · Seminars in Oncology · doi:10.1016/s0093-7754(02)70128-0 · Cited by 88
From p63 to p53 across p73
Strano, S., Rossi, M., Fontemaggi, G., Munarriz, E. R., Soddu, S., Sacchi, A., & Blandino, G. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02119-6 · Cited by 87
A New Twist in the Feedback Loop: Stress-Activated MDM2 Destabilization is Required for p53 Activation
Stommel, J. M., & Wahl, G. M. (2005) · Cell Cycle · doi:10.4161/cc.4.3.1522 · Cited by 90
AMF-1/Gps2 Binds p300 and Enhances Its Interaction with Papillomavirus E2 Proteins
Peng, Y.-C., Breiding, D. E., Sverdrup, F. M., Richard, J. G., & Androphy, E. J. (2000) · Journal of Virology · doi:10.1128/jvi.74.13.5872-5879.2000 · Cited by 86
MDM2 Inhibits PCAF (p300/CREB-binding Protein-associated Factor)-mediated p53 Acetylation
Jin, Y., Zeng, S. X., Dai, M., Yang, X., & Lu, H. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204078200 · Cited by 86
Pharmacological blockade of a β2AR-β-arrestin-1 signaling cascade prevents the accumulation of DNA damage in a behavioral stress model
Hara, M. R., Sachs, B. D., Caron, M. G., & Lefkowitz, R. J. (2013) · Cell Cycle · doi:10.4161/cc.23368 · Cited by 87
Roles of CREB-binding protein (CBP)/p300 in respiratory epithelium tumorigenesis
Karamouzis, M. V., Konstantinopoulos, P. A., & Papavassiliou, A. G. (2007) · Cell Research · doi:10.1038/cr.2007.10 · Cited by 88
Correlation of AIB1 overexpression with advanced clinical stage of human colorectal carcinoma
Xie, D., Sham, J. S. T., Zeng, W.-F., Lin, H.-L., Bi, J., Che, L.-H., Hu, L., Zeng, Y.-X., & Guan, X. (2005) · Human Pathology · doi:10.1016/j.humpath.2005.05.007 · Cited by 84
Balance of Yin and Yang: Ubiquitylation-Mediated Regulation of p53 and c-Myc
Dai, M., Jin, Y., Gallegos, J. R., & Lu, H. (2006) · Neoplasia · doi:10.1593/neo.06334 · Cited by 85
Acetylation-dependent regulation of MDM2 E3 ligase activity dictates its oncogenic function.
Nihira, N. T., Ogura, K., Shimizu, K., North, B. J., Zhang, J., Gao, D., Inuzuka, H., & Wei, W. (2017) · Science Signaling · doi:10.1126/scisignal.aai8026 · Cited by 82
Targeting HPV16 E6-p300 interaction reactivates p53 and inhibits the tumorigenicity of HPV-positive head and neck squamous cell carcinoma
Xie, X., Piao, L., Bullock, B. N., Smith, A., Su, T., Zhang, M., Teknos, T. N., Arora, P. S., & Pan, Q. (2013) · Oncogene · doi:10.1038/onc.2013.25 · Cited by 80
A Specific Survival Response in Dopamine Neurons at Most Risk in Parkinson's Disease
Murase, S., & McKay, R. D. G. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.2745-06.2006 · Cited by 80
TRIM25 has a dual function in the p53/Mdm2 circuit
Zhang, P., Elabd, S., Hammer, S., Solozobova, V., Yan, H., Bartel, F., Inoue, S., Henrich, T., Wittbrodt, J., Loosli, F., et al. (2015) · Oncogene · doi:10.1038/onc.2015.21 · Cited by 79
Increased Radioresistance and Accelerated B Cell Lymphomas in Mice with Mdmx Mutations that Prevent Modifications by DNA-Damage-Activated Kinases
Wang, Y. V., Leblanc, M., Wade, M., Jochemsen, A. G., & Wahl, G. M. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.05.008 · Cited by 79
Estrogen receptor protects p53 from deactivation by human double minute-2.
Liu, G., Schwartz, J. A., & Brooks, S. C. (2000) · PubMed · Cited by 79
Cell Transformation by Human Adenoviruses
Endter, C., & Dobner, T. (2004) · Current topics in microbiology and immunology · doi:10.1007/978-3-662-05599-1_6 · Cited by 80
Life and death of transcriptional co-activator p300
Chen, J., & Li, Q. (2011) · Epigenetics · doi:10.4161/epi.6.8.16065 · Cited by 81
p53 protects against LPS-induced lung endothelial barrier dysfunction
Barabutis, N., Dimitropoulou, C., Birmpas, C., Joshi, A., Thangjam, G. S., & Catravas, J. D. (2015) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00334.2014 · Cited by 76
p53 Oligomerization Is Essential for Its C-terminal Lysine Acetylation
Itahana, Y., Ke, H., & Zhang, Y. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m805696200 · Cited by 73
Critical roles for the serine 20, but not the serine 15, phosphorylation site and for the polyproline domain in regulating p53 turnover
Dumaz, N., Milne, D., Jardine, L., & Meek, D. W. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3590459 · Cited by 75
Variant 1 of KIAA0101, overexpressed in hepatocellular carcinoma, prevents doxorubicin-induced apoptosis by inhibiting p53 activation
Liu, L., Chen, X., Xie, S., Zhang, C., Qiu, Z., & Zhu, F. (2012) · Hepatology · doi:10.1002/hep.25834 · Cited by 74
The Central Acidic Domain of MDM2 Is Critical in Inhibition of Retinoblastoma-mediated Suppression of E2F and Cell Growth
Sdek, P., Ying, H., Zheng, H., Margulis, A. R., Tang, X., Tian, K., & Xiao, Z. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406062200 · Cited by 74
Self-citation
The p53 tumor suppressor: Critical regulator of life & death in cancer
Fisher, D. E. (2001) · APOPTOSIS · doi:10.1023/a:1009659708549 · Cited by 74
Involvement of Protein Kinase Cε (PKCε) in Thyroid Cell Death
Knauf, J. A., Elisei, R., Mochly‐Rosen, D., Liron, T., Chen, X., Gonsky, R., Korenberg, J. R., & Fagin, J. A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.33.23414 · Cited by 73
A post-ubiquitination role for MDM2 and hHR23A in the p53 degradation pathway
Brignone, C., Bradley, K., Kisselev, A. F., & Grossman, S. R. (2004) · Oncogene · doi:10.1038/sj.onc.1207540 · Cited by 73
Self-citation
The p53 response: Emerging levels of co-factor complexity
Coutts, A. S., & La Thangue, N. B. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.03.150 · Cited by 72
Cytoplasmically “Sequestered” Wild Type p53 Protein Is Resistant to Mdm2-mediated Degradation
Zaika, A. I., Marchenko, N. D., & Moll, U. M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.39.27474 · Cited by 72
Merlin Neutralizes the Inhibitory Effect of Mdm2 on p53
Kim, H., Kwak, N., Lee, J., Choi, B. H., Lim, Y., Ko, Y. J., Kim, Y.-H., Huh, P., Lee, K.-H., Rha, H. K., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m305526200 · Cited by 71
p76MDM2 Inhibits the Ability of p90MDM2to Destabilize p53
Perry, M. E., Mendrysa, S. M., Saucedo, L. J., Tannous, P., & Holubar, M. K. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.8.5733 · Cited by 71
The E7 Oncoprotein of Human Papillomavirus Type 16 Stabilizes p53 through a Mechanism Independent of p19 ARF
Seavey, S. E., Holubar, M. K., Saucedo, L. J., & Perry, M. E. (1999) · Journal of Virology · doi:10.1128/jvi.73.9.7590-7598.1999 · Cited by 69
Regulation of the p53 Family Proteins by the Ubiquitin Proteasomal Pathway
Bang, S., Kaur, S., & Kurokawa, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms21010261 · Cited by 69
p53 mediates the negative regulation of MDM2 by orphan receptor TR3
Zhao, B., Chen, H., Lei, N., Li, G., Zhao, W., Zhan, Y.-Y., Liu, B., Lin, S., & Wu, Q. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601435 · Cited by 69
p63 and p73: old members of a new family
Marín, M. C., & Kaelin, W. G. (2000) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(00)00010-x · Cited by 67
Mechanisms underlying fibronectin‐induced up‐regulation of P2X4R expression in microglia: distinct roles of PI3K–Akt and MEK–ERK signalling pathways
Tsuda, M., Toyomitsu, E., Kometani, M., Tozaki‐Saitoh, H., & Inoue, K. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00719.x · Cited by 66
Rush hour at the promoter: How the ubiquitin-proteasome pathway polices the traffic flow of nuclear receptor-dependent transcription
Dennis, A. P., & O’Malley, B. W. (2005) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2004.12.015 · Cited by 70
The p53 family: same response, different signals?
Chen, X. (1999) · Molecular Medicine Today · doi:10.1016/s1357-4310(99)01545-2 · Cited by 67
Regulation of Hypoxia-inducible Factor 1α (HIF-1α) by Lysophosphatidic Acid Is Dependent on Interplay between p53 and Krüppel-like Factor 5
Lee, S., No, Y. R., Dang, D. T., Dang, L. H., Yang, V. W., Shim, H., & Yun, C. C. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.489708 · Cited by 68
Complex Regulation of the Transactivation Function of Hypoxia-inducible Factor-1α by Direct Interaction with Two Distinct Domains of the CREB-binding Protein/p300
Ruas, J. L., Berchner‐Pfannschmidt, U., Malik, S., Gradin, K., Fandrey, J., Roeder, R. G., Pereira, T., & Poellinger, L. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.021824 · Cited by 68
Mdm2 targets the p53 transcription cofactor JMY for degradation
Coutts, A., Boulahbel, H., Graham, A., & Thangue, N. L. (2007) · EMBO Reports · doi:10.1038/sj.embor.7400855 · Cited by 73
ATM complexes with HDM2 and promotes its rapid phosphorylation in a p53-independent manner in normal and tumor human cells exposed to ionizing radiation
de Toledo, S. M., Azzam, E. I., Dahlberg, W. K., Gooding, T. B., & Little, J. B. (2000) · Oncogene · doi:10.1038/sj.onc.1204020 · Cited by 64
Epigenetic Mechanisms of Rubinstein–Taybi Syndrome
Park, E., Kim, Y., Ryu, H., Kowall, N. W., Lee, J., & Ryu, H. (2014) · NeuroMolecular Medicine · doi:10.1007/s12017-013-8285-3 · Cited by 63
Genome-Wide Identification of Molecular Pathways and Biomarkers in Response to Arsenic Exposure in Zebrafish Liver
Xu, H., Lam, S. H., Shen, Y., & Gong, Z. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068737 · Cited by 66
Two Distinct Motifs within the p53 Transactivation Domain Bind to the Taz2 Domain of p300 and Are Differentially Affected by Phosphorylation
Jenkins, L. M. M., Yamaguchi, H., Hayashi, R., Cherry, S., Tropea, J. E., Miller, M., Wlodawer, A., Appella, E., & Mazur, S. J. (2009) · Biochemistry · doi:10.1021/bi801716h · Cited by 64

Authors: Grossman, S. R., Perez, M., Kung, A. L., Joseph, M., Mansur, C., Xiao, Z.-X., Kumar, S., Howley, P. M., & Livingston, D. M.
Affiliations: Harvard University (US)
Tufts University (US)
Boston University (US)
Corresponding author: Livingston, David M
ORCID: Grossman, Steven R
Perez, Marco
Kung, Andrew L
Joseph, Michael
Xiao, Zhi-Xiong
Kumar, Sushant
Howley, Peter M
Livingston, David M
Venue: Molecular Cell
Publisher: Elsevier BV
Published: 1998-10
Volume: 2
Issue: 4
Pages: 405-415
ISSN: 1097-2765 (ISSN-L)
DOI: 10.1016/s1097-2765(00)80140-9
OpenAlex: W2063877452
Cited by: 414
References: 63
Citations by year: 2026: 2 · 2025: 4 · 2024: 3 · 2023: 7 · 2022: 7 · 2021: 4 · 2020: 9 · 2019: 4 · 2018: 6 · 2017: 2 · 2016: 9 · 2015: 4 · 2014: 15 · 2013: 15 · 2012: 18
FWCI: 19.07
Type: journal article
Language: en
Open access: hybrid
doi.org
Licence: cc-by-nc-nd
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
creativecommons.org/licenses/by-nc-nd/4.0/ (vor, 923 d)
Locations: Molecular Cell (publishedVersion, cc-by-nc-nd)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
Keywords: P300, MDM2, p53 degradation, CBP, adenovirus E1A, protein-protein interaction, p53 stabilization, tumor suppressor regulation
MeSH terms: Cell Line, DNA-Binding Proteins, Humans, Molecular Sequence Data, Neoplasm Proteins, Nuclear Proteins, Oncogene Proteins, Viral, Protein Binding, Proto-Oncogene Proteins, Ubiquitins, Trans-Activators, Tumor Suppressor Protein p53, Mutagenesis, Sequence Homology, Amino Acid, Proto-Oncogene Proteins c-mdm2

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

p300/MDM2 Complexes Participate in MDM2-Mediated p53 Degradation

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks